Scarica l'app Stockscreener
575.24
0.90%
-5.21
Dopo l'orario di chiusura:
575.01
-0.23
-0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$580.45
Aprire:
$579.03
Volume 24 ore:
1.96M
Relative Volume:
0.97
Capitalizzazione di mercato:
$216.12B
Reddito:
$43.74B
Utile/perdita netta:
$6.58B
Rapporto P/E:
33.24
EPS:
17.3072
Flusso di cassa netto:
$6.11B
1 W Prestazione:
-3.04%
1M Prestazione:
+1.77%
6M Prestazione:
+42.51%
1 anno Prestazione:
+8.77%
Intervallo 1D:
$560.16
$580.45
Intervallo di 1 settimana:
$560.16
$597.68
Portata 52W:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
575.24 | 218.08B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.13 | 161.37B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.35 | 57.97B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.32 | 42.25B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
224.92 | 38.70B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific axpands Bioprocess Design Centers to strengthen Asia’s biopharma manufacturing capacity - BioMelbourne Network
Insider Selling: Thermo Fisher Scientific (NYSE:TMO) EVP Sells 6,912 Shares of Stock - MarketBeat
Thermo Fisher Scientific (TMO): Reassessing Valuation After Recent Share Price Gains - simplywall.st
Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening - Benzinga
BioNexus gets $500M to step into manufacturing; Thermo Fisher, AtomVie expand - Endpoints News
What Made Thermo Fisher Scientific (TMO) a Solid Performer in Q3? - Insider Monkey
How Thermo Fisher Scientific Inc. (Common Stock) (TN80) stock gains from tech spendingJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - Newser
GENinCode Plc (AIM: GENI) up 33% on Thermo Fisher commercialisation deal - Share Talk
GENinCode surges on Thermo Fisher deal to roll out heart-disease test - Proactive Investors
GENinCode Partners with Thermo Fisher for CARDIO inCode-Score® Expansion - TipRanks
Thermo Fisher Scientific(TMO.US) Officer Sells US$8.15 Million in Common Stock - 富途牛牛
Thermo Fisher launches purpose-built next-gen triple quad mass spec - SelectScience
Jim Cramer Says He Feels “Particularly Good About” Thermo Fisher - Insider Monkey
Thermo Fisher Scientific Insider Sold Shares Worth $8,154,131, According to a Recent SEC Filing - marketscreener.com
Thermo Fisher Scientific (TMO) SVP & General Counsel reports Form 4 stock sale - Stock Titan
Thermo Fisher (TMO) EVP Lowery discloses December 2025 option exercises and share sales - Stock Titan
TMO (NYSE: TMO) insider Michel Lagarde files Form 144 to sell 32,000 shares - Stock Titan
TMO Stock Benefits From New Bioprocess Design Center in Asia - TradingView
Thermo Fisher Scientific Expands Bioprocessing Capabilities Across Asia - Contract Pharma
New Bioprocess Design Center In Hyderabad Boosts Thermo Fisher’s Asian Bioprocessing Capabilities - Sahyadri Startups
India could scale semiconductor manufacturing faster than expected, says Thermo Fisher leaders - ET Manufacturing
Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers - BioSpectrum Asia
Thermo Fisher expands bioprocessing capabilities across Asia - Investing.com
Thermo Fisher expands bioprocessing capabilities across Asia By Investing.com - Investing.com India
Thermo Fisher (TMO) boosts Asia biopharma support with new and expanded design centers - Stock Titan
COO Lagarde Files To Sell 30,000 Of Thermo Fisher Scientific Inc [TMO] - TradingView
Thermo Fisher Scientific (TMO) insider files to sell 30,000 shares worth 17,457,611.41 - Stock Titan
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com
Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts - ts2.tech
Thermo Fisher Scientific (NYSE: TMO) insider plans sale of 6,912 shares - Stock Titan
Thermo Fisher Scientific Inc (TMO) Stock Forecasts - Yahoo Finance
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $670 From $656, Keeps Overweight Rating - marketscreener.com
As the bio industry grows, Thermo Fisher Scientific (TMO), the world's No. 1 producer of life scienc.. - 매일경제
Thermo Fisher Scientific issues €2.1 billion in euro-denominated senior notes - Investing.com Nigeria
Thermo Fisher (TMO) Raises €2.1 Billion Through Floating and Fixed-Rate Senior Notes - MSN
Is Thermo Fisher Scientific Inc. (TN8) stock among top earnings playsJuly 2025 Action & Long-Term Growth Stock Strategies - Newser
HSBC Upgrades Thermo Fisher Scientific (TMO) - Nasdaq
Morgan Stanley assumes coverage on Thermo Fisher stock with Overweight rating - Investing.com
Thermo Fisher Issues €2.1 Billion in Senior Notes - TipRanks
Thermo Fisher Scientific (NYSE: TMO) prices €2.09B in 2027 and 2035 notes - Stock Titan
Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts - ts2.tech
VP Lowery Files To Sell 6,913 Of Thermo Fisher Scientific Inc [TMO] - TradingView
Thermo Fisher (NYSE: TMO) insider plans Rule 144 sale of 6,913 common shares - Stock Titan
Pittsburgh Playhouse, Thermo Fisher Scientific, East End Food Co-op and more: Pittsburgh jobs for 12/1/25 - NEXTpittsburgh
Thermo Fisher Scientific launches CorEvitas Clinical Registry for rare autoimmune disorder - scientistlive.com
FDA approves lung cancer diagnostic test - scientistlive.com
Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA - Yahoo Finance
HSBC Upgrades Thermo Fisher Scientific to Buy From Hold, Adjusts Price Target to $670 From $550 - marketscreener.com
Is Thermo Fisher Scientific Inc TN8 a good long term investmentBull Market Opportunities & Double Digit Profit Strategies - earlytimes.in
10 Best Dividend Stocks Hedge Funds Are Buying - Insider Monkey
American Century Companies Inc. Decreases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.58%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):